Pain and Pain Management

Published on 07/03/2015 by admin

Filed under Critical Care Medicine

Last modified 22/04/2025

Print this page

rate 1 star rate 2 star rate 3 star rate 4 star rate 5 star
Your rating: none, Average: 0 (0 votes)

This article have been viewed 6877 times

Pain and Pain Management

Céline Gélinas and Caroline Arbour

Despite national and international efforts, guidelines, standards of practice, position statements, and many important discoveries in the field of pain management in the past three decades, critically ill patients suffer from moderate to severe pain that can be experienced at rest or during routine care.1,2 For instance, chest tube removal, turning, drain removal, and wound care were identified as the most painful procedures by critically ill adults in previous studies.24 Despite this situation, pain remains undertreated in most critically ill patients.5 Poor treatment of acute pain may lead to the development of serious complications6,7 and chronic pain syndromes,810 which may seriously impact the patient’s functioning, quality of life, and well-being. Such evidence reinforces the importance of providing attention to pain in this specific context of care.

Importance of Pain Assessment

Appropriate pain assessment is the foundation of effective pain treatment. Because pain is recognized as a subjective experience, the patient’s self-report is considered the most valid measure for pain and should be obtained as often as possible.11 Unfortunately in critical care, many factors such as the administration of sedative agents, the use of mechanical ventilation, and altered levels of consciousness may impact communication with patients.12,13 These obstacles make pain assessment more complex. Nevertheless, except for being unable to speak, many mechanically ventilated patients can communicate that they are in pain by using head nodding, hand motions or by seeking attention with other movements.4 In such a situation, use of appropriate communication methods may reduce patients’ distress associated with the presence of the endotracheal tube by enabling them to report the presence of pain or discomfort in a comprehensive way.14

Self-report pain intensity scales have been used with postoperative mechanically ventilated patients who were asked to point on the scale.2,15 However, in a study of mechanically ventilated adults with various diagnoses (trauma, surgical, or medical), only one third of mechanically ventilated patients were able to use a pain intensity scale.15 With a greater degree of critical illness, providing a pain intensity self-report becomes more difficult because it requires concentration and energy. When the patient is unable to communicate in any way, observable behavioral indicators become unique indices for pain assessment and are part of clinical guidelines and recommendations developed in North America.16,17 Pain is frequently encountered in critical care, and there is increased emphasis on the professional responsibility to manage the patient’s pain effectively. The critical care nurse must understand the mechanisms, assessment process, and appropriate therapeutic measures for managing pain.

This chapter provides nurses with a better understanding of the physiology of pain. It also demonstrates indicators that can be used for pain assessment and several methods for pain management in critically ill patients.

Definition and Description of Pain

Pain is described as an unpleasant sensory and emotional experience associated with actual or potential tissue damage or described in terms of such damage.18 This definition emphasizes the subjective and multidimensional nature of pain. More specifically, the subjective characteristic implies that pain is whatever the person experiencing it says it is and that it exists whenever he or she says it does.19 This definition also suggests that the patient is able to self-report. However, in the critical care context, many patients are unable to self-report their pain. Some authors20 have proposed an alternative definition for nonverbal patients, in this case infants, but the same principle applies to any non-verbal population, stating that changes in behaviors caused by pain are valuable forms of self-report and should be considered as alternative measures of pain. Based upon this, pain assessment must be designed to conform to the communication capabilities of the patient.

Types of Pain

Pain can be acute or chronic, with different sensations related to the origin of the pain.

Nociceptive Pain

Nociceptive pain arises from activation of nociceptors,11 and it can be somatic or visceral. Somatic pain involves superficial tissues, such as the skin, muscles, joints, and bones. Its location is well defined. Visceral pain involves organs such as the heart, stomach, and liver. Its location is diffuse, and it can be referred to a different location in the body.24 Interestingly, not all organs are sensitive to pain and some can be damaged quite extensively without the patient feeling a thing. For instance, many diseases of the liver, the lungs or the kidneys are completely painless and the only symptoms felt are those derived from the abnormal functioning of these organs. On the other hand, relatively minor lesions in viscera such as the stomach, the bladder, or the ureters can produce excruciating pain, as these organs are abundantly innervated by sensory neurons that signal harmful events.25

Neuropathic Pain

Neuropathic pain arises from a lesion or disease affecting the somatosensory system.11 The origin of neuropathic pain may be peripheral or central. Neuralgia and neuropathy are examples related to peripheral neuropathic pain, which implies a damage of the peripheral somatosensory system. Central neuropathic pain involves the central somatosensory cortex and can be experienced by patients after a cerebral stroke. Neuropathic pain can be difficult to manage and frequently requires a multimodal approach (i.e., the combinations of several pharmacologic and/or nonpharmacologic treatments).24

Physiology of Pain

Nociception

Nociception represents the neural processes of encoding and processing noxious stimuli necessary, but not sufficient, for pain.11 Pain results from the integration of the pain-related signal into specific cortical areas of the brain associated with higher mental processes and consciousness. In other words, pain is the conscious experience that emerges from nociception.26 Four processes are involved in nociception24:

The four processes are shown in Figure 9-1, which integrates pain assessment with nociception, and in Figure 9-2.

Transmission

As a result of transduction, an action potential is produced and is transmitted by nociceptive nerve fibers in the spinal cord that reach higher centers of the brain. This is called transmission, and it represents the second process of nociception. The principal nociceptive fibers are the A-delta (Aδ) and C fibers. Large-diameter, myelinated Aδ fibers that transmit well-localized, sharp pain are involved in “first pain” sensation, which leads to reflex withdrawal. Small-diameter, unmyelinated C fibers transmit diffuse, dull, aching pain, which is referred to as “second pain.”26 These fibers transmit the noxious sensation from the periphery through the dorsal root of the spinal cord. With the liberation of substance P, these fibers then synapse with ascending spinothalamic fibers to the central nervous system (CNS). These spinothalamic fibers are clustered into two specific pathways: neospinothalamic (NS) and paleospinothalamic (PS) pathways. Generally, the Aδ fibers transmit the pain sensation to the brain within the NS pathway, and the C fibers use the PS pathway.27

Through synapsing of nociceptive fibers with motor fibers in the spinal cord, muscle rigidity can appear because of a reflex activity.28 Muscle rigidity can be a behavioral indicator associated with pain. It can contribute to immobility and decrease diaphragmatic excursion. This can lead to hypoventilation and hypoxemia. Hypoxemia can be detected by a pulse oximeter (Spo2) and by oxygen arterial pressure (Pao2) monitoring. A ventilated patient’s interaction with the machine (e.g., activation of alarms, fighting the ventilator) also may indicate the presence of pain.29

Perception

The pain message is transmitted by the spinothalamic pathways to centers in the brain, where it is perceived. Pain sensation transmitted by the NS pathway reaches the thalamus, and the pain sensation transmitted by the PS pathway reaches brainstem, hypothalamus, and thalamus.27 These parts of the CNS contribute to the initial perception of pain. Projections to the limbic system and the frontal cortex allow expression of the affective component of pain.30 Projections to the sensory cortex located in the parietal lobe allow the patient to describe the sensory characteristics of his or her pain, such as location, intensity, and quality.30,31 The cognitive component of pain involves many parts of the cerebral cortex and is complex. These three components (affective, sensory, and cognitive) represent the subjective interpretation of pain. Parallel to this subjective process, certain facial expressions and body movements are behavioral indicators of pain occurring as a result of pain fiber projections to the motor cortex in the frontal lobe.

Modulation

Modulation is a process by which noxious stimuli that travel from the nociceptive receptors to the CNS may be enhanced or inhibited. Pain can be modulated by ascending and descending mechanisms. A typical example of ascending pain modulation is rubbing an injury site, thus activating large A-beta (Aβ) fibers in the periphery. Stimulation of these fibers activates inhibitory interneurons in the dorsal horn of the spinal cord, effectively preventing nociceptive signal transmission from the periphery to the higher brain regions. The physiologic basis of this mechanism of pain modulation was elucidated by Melzack and Wall in 196532 and refers to the Gate Control Theory (GCT). Analgesia may also be produced at the level of the spinal cord and the brainstem (spinothalamic pathway) via the release of endogenous opioids and neurotransmitters. Endogenous opioids are naturally occurring morphine-like pentapeptides found throughout the nervous system and exist in three general classes: beta-endorphins, enkephalins, and dynorphins. These substances block neuronal activity related to nociceptive impulses by binding to opioid mu (µ) receptor sites in the central and peripheral nervous systems.27 In the ascending pain modulation mechanism, endogenous opioids may be produced in the brainstem, and the dorsal horn or exogenous opioids may be introduced by administration of an opioid analgesic. The released or introduced opioids bind to the mu-opioid receptors on nociceptive nerve fibers, blocking the release of substance P. In the descending pain modulation mechanism, the efferent spinothalamic nerve fibers that descend from the brain can inhibit the propagation of the pain signal by triggering the release of endogenous opioids in the brain stem and in the spinal cord. Serotonin and norepinephrine are important inhibitory neurotransmitters that act in the CNS. These substances are also released by the descending fibers of the descending spinothalamic pathway.33 The use of distraction, relaxation and imagery techniques can facilitate the release of endogenous opioids, and has been shown to reduce the overall pain experience.34

In summary, nociception is an important physiologic mechanism of pain that can integrate many components of pain for its assessment. In transduction, stimuli are sources of pain that trigger the liberation of neurotransmitters. In transmission, diffusion of the action potential along the NS pathway may lead to muscle rigidity—a reflex activity that can be observed as a behavioral indicator associated with pain. Muscle rigidity may also influence respiratory rate and amplitude, and cause decrease in Spo2 and increase in Pao2. In perception, the patient’s self-report of affective, sensory, and cognitive information can be obtained, and behavioral responses to pain may also be observed. Finally, in modulation, pain sensation may be attenuated by ascending and descending mechanisms.

Biologic Stress Response

A biologic stress response is activated by pain, an obvious stressor.29 This stress response involves the nervous, endocrine, and immune systems in the hypothalamic-pituitary-adrenal axis (HPA).35 The biologic stress response includes a short-term direct response, a midterm response, and a long-term indirect response. Stress mechanisms are depicted in Figure 9-3.

Short-Term Direct Response

In the presence of a stressor such as pain, the hypothalamus releases corticotropin-releasing factor (CRF), which activates the sympathetic nervous system (SNS). Norepinephrine is then released from the terminals of sympathetic nerves, and epinephrine is released from the adrenal cortex. This mechanism constitutes the short-term direct stress response. The effects of these stress hormones allow observation of physiologic responses associated with activation of SNS. For instance, increased blood pressure, increased heart rate, and increased respiratory rate are common signs of acute pain.15,29,36 Moreover, pupil dilation can be observed.37

If pain persists over time or injuries are located in the bladder or the intestines, the parasympathetic nervous system (PNS) may be dominant. The blood pressure and heart rate may decrease rather than increase. The absence of pain-related indicators related to the activation of the SNS does not necessarily imply an absence of pain sensation.38

Midterm Indirect Response

At midterm, the CRF released from the hypothalamus stimulates the anterior pituitary to release adrenocorticotropic hormone (ACTH) and the posterior pituitary to release vasopressin, the antidiuretic hormone. ACTH activates the adrenal cortex to release aldosterone and cortisol. Vasopressin and aldosterone increase sodium and water retention. This increases intravascular volume and decreases diuresis and increases blood pressure and cardiac preload. Cortisol also may contribute to systemic responses such as infection and hyperglycemia.

At midterm, pain may be associated with decreased diuresis, increased blood pressure, increased central venous pressure (CVP), and increased pulmonary artery capillary occlusion pressure (PAOP). However, changes in these parameters are not specific to pain, and their associations with pain are not supported by empirical data.

Long-Term Indirect Response

Long term, the stress hormones, specifically cortisol, influence the immune system in two ways: immunosuppression and release of cytokines.39 Cytokines may prolong by retroactivation the release of cortisol, which may exacerbate tissue damage, contributing to the chronic pain process.23

In summary, the biologic stress response allows observation of fluctuations in physiologic signs that represent a source of stress and may be associated with acute pain. The short-term signs are mainly related to SNS activation. Other signs, such as decreased diuresis and increased CVP and PAOP, relate to the midterm indirect stress response. The immune system is involved in the long-term indirect response of stress. No acute pain indicators have been associated with this process. All the indicators identified within the biologic stress response are not specific to pain because they can be attributed to other distress conditions, homeostatic changes, and medications.16

Framework for Pain Assessment and Definition

As previously stated, self-report of pain is not always possible to obtain in critically ill patients as many of them may be unable to communicate during their stay in the critical care unit. When the patient is unable to self-report, the expression of pain can be examined from the perspective of the Communications Model of Pain.40 The foundation of this model is that observational measures capture behaviors that are less subject to voluntary control and more automatic in comparison with self-report measures that depend on higher mental processes. Consequently, observational measures should be used to assess pain when the individual’s self-report is not available, as is often the case in critically ill patients. This A → B → C model conceptualizes pain as an internal state (A) that may be encoded in particular features of expressive behaviors (B), allowing observers (in this case nurses) to draw inferences (C) about the nature of the sender’s experience (Fig. 9-4).

More specifically, when an individual is exposed to a nociceptive stimulus known to be painful, information about real or potential tissue damage is transmitted and processed centrally into the brain. The processing of a nociceptive stimulus can be modulated by intrapersonal and/or contextual factors influencing the way information is integrated and consequently how pain is experienced in each individual. In critical care, intrapersonal factors that could potentially influence the processing of a nociceptive stimulus include the patient’s socio-demographic characteristics, severity of critical illness/injury, level of sedation, and level of consciousness. Similarly, examples of contextual factors specific to the critical care unit environment that could influence the patient’s pain experience include mechanical ventilation and administration of sedatives and opioids. Taking into account the various intrapersonal and contextual factors, critically ill patients may express their pain through different patterns of verbal and nonverbal expressive modalities. The depicted pattern will depend largely on the degree of impairment in the cortical areas of the brain associated with consciousness. Indeed, while some patients with a mild alteration of the level of consciousness may still have the capacity to self-report and/or express their pain with voluntary behaviors (e.g., localization of the pain site), others with a severe alteration of the level of consciousness might respond to pain only through autonomic reactions such as reflex or fluctuations in physiologic signs. Whether patients are able to express their pain through self-report, voluntary behaviors and/or autonomic reactions will undoubtedly affect the message clarity and the capacity of nurses to identify the specific nature of patients’ pain. Because behaviors are difficult to decode, educational training of nurses is necessary to support them in developing the competence of adequately assessing pain behaviors using observational measures.

Pain Assessment

Pain assessment is an integral part of nursing care. It is a prerequisite for adequate pain control and relief. As stated earlier, pain is a subjective, multidimensional concept that requires complex assessment. Many factors may alter verbal communication in critically ill patients, making pain assessment more difficult. This situation should not discourage nurses from assessing pain in these vulnerable patients because acute pain is a stressor that can exacerbate their conditions.

Pain assessment has two major components: 1) nonobservable or subjective and 2) observable or objective. The complexity of pain assessment requires the use of multiple strategies by critical care nurses. In the following sections, patient, health professional, and organizational barriers to pain assessment and management are addressed, and recommendations are proposed.

Pain Assessment: The Subjective Component

Pain is known as a subjective experience. The subjective component of pain assessment refers to the patient’s self-report about his or her sensorial, affective, and cognitive experience of pain. Because it is considered the most valid measure of pain, the patient’s self-report must be obtained whenever possible.16 A simple yes or no (presence versus absence of pain) is a valid self-report. Mechanical ventilation should not be a barrier for nurses to document patients’ self-reports of pain. Many mechanically ventilated patients can communicate that they have pain or can use pain scales by pointing to numbers or symbols on the scale.2,4,15 Attempts should be made before concluding that a patient is unable to self-report. More importantly, sufficient time should be allowed for the patient to respond with each attempt.16

If sedation and cognition levels allow the patient to give more information about pain, a multidimensional assessment can be documented. Multidimensional pain assessment tools including the sensorial, emotional, and cognitive components are available, such as the Brief Pain Inventory,41 the Initial Pain Assessment Tool,24 and the McGill Pain Questionnaire–Short Form.42 However, because of the administration of sedative and analgesic agents in mechanically ventilated patients, the tool must be short enough to be completed. For instance, the McGill Pain Questionnaire–Short Form takes 2 to 3 minutes to complete and has been used to assess mechanically ventilated patients who were in a stable condition.2

The patient’s self-report of pain can also be obtained by questioning the patient using the mnemonic PQRSTU43:

Q: Quality

The Q in the mnemonic refers to the quality of the pain or the pain sensation that the patient is experiencing. For instance, the patient may describe the pain as dull, aching, sharp, burning, or stabbing. This information provides the nurse with data regarding the type of pain the patient is experiencing (e.g., somatic or visceral). The differentiation between types of pain may contribute to the determination of cause and management. A patient who has had open-heart surgery may complain of chest pain that is shooting or burning.4 This information can lead the nurse to investigate for cutaneous or bone injuries as a result of a sternotomy. Another patient may describe a sharp thoracic pain that may lead the nurse to consider visceral pain as a result of pulmonary embolism. A verbal description of pain is important because it provides a baseline account, allowing the critical care nurse to monitor changes in the type of pain, which may indicate a change in the underlying pathology.

R: Region or Location, Radiation

R usually is easy for the patient to identify, although visceral pain is more difficult for the patient to localize.24 If the patient has difficulty naming the location or is mechanically ventilated, ask the patient to point to the location on himself or herself or on a simple anatomic drawing.44

S: Severity and Other Symptoms

S, the severity or intensity of pain, is a measurement that has undergone much investigation. Many pain intensity scales are available, including the descriptive and numeric pain rating scales that are often used in the critical care environment (Fig. 9-5). Many critical care units use a specific pain intensity scale. The use of a single tool provides consistency of assessment and documentation. Employment of a pain intensity scale is useful in the critical care environment. Asking the patient to grade his or her pain on a scale of 0 to 10 is a consistent method and aids the nurse in objectifying the subjective nature of the patient’s pain. However, the patient’s tool preference should be considered.

The S in the mnemonic also refers to other symptoms accompanying the patient’s pain experience, such as shortness of breath, nausea, and fatigue. Anxiety and fear are common emotions associated with pain.

U: Understanding

The U in the mnemonic is the patient’s perception of the problem or cognitive experience of pain. Patients with known cardiac problems can tell the nurse whether their pain is the same as they had during myocardial infarction. Patients with a cerebral hemorrhage often describe experiencing the worst headache they have ever had.

Because of the patient’s change in communication, lack of concentration due to sedation therapies, and the life-or-death immediacy of most actions in the critical care environment, pain assessment is often reduced to minimal information. Begin by asking, “Do you have pain?” The use of a simple yes or no question allows the patient to answer verbally or to indicate his or her response by nodding the head or by other signs. It is easier for mechanically ventilated patients to communicate with nurses in this way because they cannot express themselves verbally. Pain intensity and location also are necessary for the initial assessment of pain.

Pain Assessment: The Observable or Objective Component

When the patient’s self-report is impossible to obtain, nurses can rely on the observation of behavioral indicators, which are strongly emphasized in clinical recommendations and guidelines for pain management in nonverbal patients.16,17 Fluctuations in vital signs should never be used alone but rather considered as a cue to begin further assessment for pain.

Pain-related behaviors have been described in critically ill patients and were also studied in the AACN Thunder Project II.45 Patients who experienced pain during nociceptive procedures were three times more likely to have increased behavioral responses such as facial expressions, muscle rigidity, and vocalization than patients without pain. Similar observations were found in a study of 257 mechanically ventilated critically ill adults.30 Patients who experienced pain during turning showed significantly more intense facial expressions (e.g., grimacing), muscle rigidity, and less compliance with the ventilator (e.g., fighting the ventilator) compared with patients without pain. Behavioral indicators are strongly recommended for pain assessment in nonverbal patients,16 and several tools have been developed and tested in critically ill adults including the Behavioral Pain Scale (BPS),46 the Critical-Care Pain Observation Tool (CPOT),47 the NonVerbal Pain Scale (NVPS),48 the Pain Behavioral Assessment Tool (PBAT),46 and the Pain Assessment and Intervention Notation (PAIN) algorithm.39 The BPS and the CPOT are supported by experts in critical care49,50 and are suggested for use in medical, postoperative, and non-brain trauma critically ill adults unable to self-report in the clinical guidelines of the Society of Critical Care Medicine (SCCM).17 Moreover, their implementation in critical care units has led to enhanced nursing practices of pain assessment and management,51 and improved patient outcomes including shorter durations of mechanical ventilation and stay in the critical care unit.52

Behavioral Pain Scale

The BPS shown in Table 9-1 was tested mostly in nonverbal mechanically ventilated patients with altered levels of consciousness.46,5356 Its validity was supported with significantly higher BPS scores during nociceptive procedures (e.g., turning, endotracheal suctioning, peripheral venous cannulation) compared with rest or nonnociceptive procedures (e.g., arterial catheter dressing change, compression stocking applications, eye care). The authors of the BPS determined a cut-off score greater than 5 for the presence of pain. A positive association was found between nurses’ BPS ratings and conscious sedated patients’ self-report of pain intensity during turning.54 Good interrater reliability of BPS scores between several raters including nurses was reached. The BPS can be used quickly (2 to 5 minutes), and most clinicians were satisfied with its ease of use.46 However, some expressed concerns about the lack of conceptual clarity of certain items.49 For instance, scores of 3 (i.e., fighting ventilator) and 4 (i.e., unable to control ventilation) for compliance with the ventilator category may be ambiguous. Similarly, movements with upper limbs category may be confused with muscle tension.

TABLE 9-1

BEHAVIORAL PAIN SCALE (BPS)

ITEM DESCRIPTION SCORE
Facial expression Relaxed 1
  Partially tightened (e.g., brow lowering) 2
  Fully tightened (e.g., eyelid closing) 3
  Grimacing 4
Upper limbs No movement 1
  Partially bent 2
  Fully bent with finger flexion 3
  Permanently retracted 4
Compliance with ventilation Tolerating movement 1
Coughing but tolerating ventilation for most of the time 2
  Fighting ventilator 3
  Unable to control ventilation 4
Total   3 to 12

image

From Payen JF, et al. Assessing pain in the critically ill sedated patients by using a behavioral pain scale. Crit Care Med. 2001;29(12):2258.

Critical-Care Pain Observation Tool

The CPOT shown in Table 9-2 was tested in verbal and nonverbal, critically ill adult patients.15,29,47,57 Content validity was supported by critical care unit expert clinicians, including nurses and physicians.58 Validity of the CPOT was supported with significantly higher CPOT scores during a nociceptive procedure (e.g., turning with or without other care) compared with rest or a nonnociceptive procedure (e.g., taking blood pressure). Positive associations were found between the CPOT scores and the patient’s self-report of pain.15,29,47 A cut-off score greater than 2 was established with the CPOT in postoperative critical care unit adults.59 Similarly to the BPS, good interrater reliability of CPOT scores was achieved with critical care nurses.15,47 Feasibility and clinical utility of the CPOT were positively evaluated by critical care nurses.60 Nurses agreed that the CPOT was quick enough to be used in the critical care unit, simple to understand, easy to complete, and helpful for nursing practice. An online teaching video to learn how to use the CPOT at the bedside is available (see Table 9-2).

TABLE 9-2

CRITICAL CARE PAIN OBSERVATION TOOL (CPOT)

INDICATOR SCORE DESCRIPTION
Facial expression

image

Relaxed, neutral 0 No muscle tension observed
Tense 1 Presence of frowning, brow lowering, orbit tightening and levator contraction or any other change (e.g., opening eyes or tearing during nociceptive procedures)
Grimacing 2 All previous facial movements plus eyelid tightly closed (the patient may present with mouth open or biting the endotracheal tube)
Body movements Absence of movements or normal position 0 Does not move at all (doesn’t necessarily mean absence of pain) or normal position (movements not aimed toward the pain site or not made for the purpose of protection)
Protection 1 Slow, cautious movements, touching or rubbing the pain site, seeking attention through movements
Restlessness/Agitation 2 Pulling tube, attempting to sit up, moving limbs/thrashing, not following commands, striking at staff, trying to climb out of bed
Compliance with the ventilator (intubated patients)
or
Vocalization (nonintubated patients)
Tolerating ventilator or movement 0 Alarms not activated, easy ventilation
Coughing but tolerating 1 Coughing, alarms may be activated but stop spontaneously
Fighting ventilator 2 Asynchrony: blocking ventilation, alarms frequently activated
Talking in normal tone or no sound 0 Talking in normal tone or no sound
Sighing, moaning 1 Sighing, moaning
Crying out, sobbing 2 Crying out, sobbing
Muscle tension Relaxed 0 No resistance to passive movements
Tense, rigid 1 Resistance to passive movements
Very tense or rigid 2 Strong resistance to passive movements, incapacity to complete them
TOTAL   ___ / 8  

1. The patient must be observed at rest for one minute to obtain a baseline value of the CPOT.

1.1. Observation of patient at rest (baseline).

    The nurse looks at the patient’s face and body to note any visible reactions for an observation period of one minute. She gives a score for all items except for muscle tension. At the end of the 1-minute period, the nurse holds the patient’s arm in both hands—one at the elbow, and uses the other one to hold the patient’s hand. Then, she performs a passive flexion and extension of the upper limb and feels any resistance the patient may exhibit. If the movements are performed easily, the patient is found to be relaxed with no resistance (score 0). If the movements can still be performed but with more strength, then it is concluded that the patient is showing resistance to movements (score 1). If the nurse cannot complete the movements, strong resistance is felt (score 2). This can be observed in patients who are spastic.

2. Then the patient should be observed during painful procedures (e.g., turning, wound care) to detect any changes in the patient’s behaviors.

2.2. Observation of patient during a painful procedure.

    While she’s performing a procedure known to be painful, the nurse looks at the patient’s face to note any reactions such as frowning or grimacing. These reactions may be brief or can last longer. The nurse also looks out for body movements. For instance, she looks for protective movements like the patient trying to reach or touching the pain site (e.g., surgical incision, injury site). In the mechanically ventilated patient, she pays attention to alarms and if they stop spontaneously or require that she intervenes (e.g., reassurance, administering medication). It is important that the nurse auscultates the patient to check for the position of the endotracheal tube and the presence of secretions as these factors may influence this item without being indicative of pain. According to muscle tension, the nurse can feel if the patient is resisting to the movement or not. A score 2 is given when the patient is resisting against the movement and attempts to get on his/her back.

3. The patient should be evaluated before and at the peak effect of an analgesic agent to assess whether the treatment was effective or not in relieving pain.

4. The patient should be attributed the highest score observed during the observation period.

5. The patient should be attributed a score for each behavior included in the CPOT and muscle tension should be evaluated last as it may lead to behavioral reactions not necessarily related to pain, but more to the actual stimulation. According to compliance with the ventilator, the nurse must check that the endotracheal tube is well positioned, and for the presence of secretions which could lead to higher scores for this item.

image

An online teaching video funded and created by Kaiser Permanente Northern California Nursing Research (KPNCNR) to learn how to use the CPOT at the bedside is available at http://pointers.audiovideoweb.com/stcasx/il83win10115/CPOT2011-WMV.wmv/play.asx.

Modified from Gélinas C, et al. Validation of the Critical-Care Pain Observation Tool (CPOT) in adult patients. Am J Crit Care. 2006;15:420. Figure of facial expressions a courtesy of Caroline Arbour, RN, BSc, PhD candidate, McGill University, Canada, and redrawn by Elsevier.

Use of Cut-Off Scores

A cut-off score refers to the score on a specific scale associated with the best probability of correctly ruling in or ruling out a patient with a specific condition—in this case pain. The use of a cut-off score with behavioral pain scales can help to identify when pain is highly likely to be present, and guide nurses in determining whether an intervention to alleviate pain is required or not. Also, a cut-off score can help to evaluate the effectiveness of pain-management interventions. It is important to highlight that cut-off scores are established using a criterion (i.e., a gold standard in the field). As mentioned previously, in the case of pain, the patient’s self-report is known as the gold standard criterion.11 For a case example showing how a cut-off score can be used in practice, refer to Box 9-1.

Limitations Related to the Use of Behavioral Pain Scales

Behaviors have been validated for pain assessment in critically ill patients, but they present some limitations. In fact, they are impossible to monitor in patients unable to respond behaviorally to pain such as those suffering from paralysis or under the effects of neuromuscular blocking agents. Also, behavioral responses may be blurred with the administration of high doses of sedative agents.15 Indeed, minimal behavioral responses to painful procedures were found in unconscious, mechanically ventilated critically ill adults who were more heavily sedated compared with conscious patients.29 Similar results were found in previous studies in which patients who received a higher dose of midazolam obtained a lower score on the BPS.56

In addition, behavioral pain scales developed for nonverbal critically ill patients may not be applicable for those with a brain injury and an altered level of consciousness as they were found to exhibit atypical behavioral responses to pain.29,61,62 Instead of frowning and grimacing, brain-injured patients with altered levels of consciousness seemed to react mostly by opening their eyes, showing tears, opening their mouth, and exhibiting repetitive movements of the lower limbs when exposed to pain. Further studies are needed to better understand how brain-injured patients react to painful procedures. Therefore existing behavioral pain scales may be inappropriate for this specific vulnerable group. When selecting a scale, nurses should make sure that is has been tested in a patient population and context in which they plan to use it. Indeed, a scale can only be shown to be valid with a specific group of people and in a given context.63

Physiologic Indicators

When patients cannot react behaviorally to pain, the only possible clues left for the detection of pain are physiologic indicators (i.e., vital signs). Although vital sign values generally increase during painful procedures,15,29,36,46,56 they are not consistently related to the patient’s self-report of pain, nor are they predictive of pain.15,29 For example, none of the monitored vital signs (heart rate, mean arterial pressure [MAP], respiratory rate, transcutaneous oxygen saturation [Spo2], and end-tidal CO2) predicted the presence of pain in critically ill patients.29

In the ASPMN recommendations and the SCCM guidelines, it is stated that vital signs should not be considered as primary indicators of pain because they can be attributed to other distress conditions, homeostatic changes, and medications. Changes in vital signs should instead be considered a cue to begin further assessment of pain or other stressors.16,17 Physiologic measures other than vital signs can support the nurses in detecting the presence of pain in nonverbal critically ill patients especially when behavioral indicators are no longer available.

Cerebral Monitoring and Pain Assessment

Other than vital signs, human brain reactivity has been studied using brain imaging technology such as positron emission tomography (PET) and functional magnetic resonance imaging (fMRI) in healthy individuals and in patients with clinical pain conditions.64 Many regions of the brain are involved in the perception of pain, including the somatosensory cortex, the frontal cortex, and the thalamus. The anatomic connections between these regions suggest that they function in an interactive way in encoding the different aspects of pain (sensory and affective components of pain). For instance, the somatosensory cortex plays a major role in processing the sensory component of pain, whereas the frontal cortex appears to reflect the affective component of pain.26 A closer look into brain activity may elucidate how pain inputs are first received and processed within the cerebral cortex, offering a direct and more precise indicator of pain.

Electroencephalogram

Continuous electroencephalographic (cEEG) activity is being used more frequently in critical care units, especially in the brain-injured population, to detect epileptic activity and ischemia.65 So far, few studies have examined the EEG reactivity of patients when exposed to pain. Frontal EEG activation was observed in 34 critically ill infants when exposed to a noxious stimulation (i.e. heelstroke).66 In a recent study with 32 cardiac surgery patients in a critical care unit, EEG activation was observed over the somatosensory cortex during chest tube removal only in patients who did not receive preprocedural analgesics (i.e., morphine). Interestingly, self-reported pain intensity of patients who did not receive morphine was higher than those who were administered morphine prior to chest tube removal.67

Bispectral Index

Another innovative technology, the Bispectral Index (BIS), is being explored for its relevance in the pain assessment process of critically ill, sedated patients.37,68 The primary utility of the BIS is as an objective measure of sedation levels during surgery in the operating room or during neuromuscular blocking in the critical care unit. This noninvasive monitor uses electrodes placed on the forehead, and displays a signal-processed electroencephalogram (EEG) with a digital number from 0 (flat EEG activity) to 100 (fully awake) that relates to the depth of sedation. An electromyographic (EMG) sensor that reflects muscle stimulation of the forehead is included to identify EMG artifact.

A study of 48 mechanically ventilated and sedated critically ill patients after cardiac surgery reported that the BIS value significantly increased when patients were exposed to a noxious stimulation (turning or endotracheal suctioning) instead of a nonnoxious procedure (gentle touch). However, the most commonly reported pain-related behaviors (e.g., facial expressions, body movements, tense posture, ventilator asynchrony) were not induced by the noxious stimulation in deeply sedated patients, highlighting the limitation of behaviors for pain assessment in heavily sedated critically ill patients. In a more recent study with nine sedated and mechanically ventilated critically ill patients,68 the median BIS value increased from 20% to 30% between rest and the painful procedures (turning and endotracheal suctioning). As opposed to the previous study, behavioral responses were exhibited by the patients with an increase in the median CPOT score from 0 to 3 during the procedures.

The new bilateral BIS is an alternative option to the conventional BIS monitoring system. The bilateral BIS allows the recording of EEG and EMG information of both hemispheres separately (i.e., BIS-Left and BIS-Right). As a result, the bilateral BIS could be particularly useful for pain assessment in patients with suppression of unilateral brain function, such as those with a cerebral stroke or a traumatic brain injury (TBI). For instance, in a recent pilot study with 12 critically ill TBI with altered level of consciousness,69 increases in BIS-Left (>6.6%) and BIS-Right (>7.2%) were observed in patients when exposed to turning compared with rest or a nonpainful procedure. Interestingly, the BIS increase was more pronounced on the noninjured side of the brain. Based on available study findings, the BIS may be an interesting technique to further study in critical care pain assessment because of its noninvasive nature and its suitability for use at the bedside.

Patient Barriers to Pain Assessment and Management

Communication

The most obvious patient barrier to the assessment of pain in the critical care population is an alteration in the ability to communicate. The patient who is mechanically ventilated cannot verbalize a description of the pain. If the patient can communicate in any way, such as by head nodding or pointing, he or she may report the pain in that manner. If writing is possible, the patient may be able to thoroughly describe the pain. With patients unable to self-report, the nurse relies on behavioral indicators to assess the presence of pain.

The patient’s family can contribute significantly in the assessment of pain. The family is intimately familiar with the patient’s normal responses to pain and can assist the nurse in identifying clues. A family member’s impression of a patient’s pain should be considered in the pain assessment process of the critically ill patient.16

Altered Level of Consciousness and Unconsciousness

The patient either unconscious or with an altered level of consciousness presents a dilemma for all clinicians. Because pain relies on cortical response to provide recognition, the belief that the patient with a brain injury altering higher cortical function has no perception of pain may persist. Conversely, the inability to interpret the nociceptive transmission does not negate the transmission. Interviews by Lawrence71 with 100 patients, who recalled their experiences from a time when they were unconscious in critical care, revealed that they could hear, understand, and respond emotionally to what was being said. Experts recommend assuming that patients who are unconscious or with an altered level of consciousness have pain and that they be treated the same way as conscious patients are treated when they are exposed to sources of pain.16 It has been demonstrated that behavioral and physiologic indicators of pain can be observed in reaction to a painful procedure in critically ill patients, no matter what their level of consciousness.29 Moreover, it has been shown that some cortical activation related to pain perception is still present in unconscious patients in a neurovegetative state.72 Knowing this, the critical care nurse can initiate a discussion with the other members of the health care team to formulate a plan of care for the patient’s comfort.

Older Adult Patients

Many older adult patients do not complain much about pain. Some misconceptions, such as believing that pain is a normal consequence of aging or being afraid to disturb the health care team, are barriers to pain expression for older adults.24 Cognitive deficits or delirium present additional pain assessment barriers. Many older adult patients with mild to moderate cognitive impairments and even some with severe impairment are able to use pain intensity scales.73,74 Vertical pain intensity scales are more easily understood by this group of patients and are recommended16 (see Fig. 9-5). Older adult patients with cognitive deficits should receive repeated instructions and be given sufficient time to respond. When the self-report of pain is impossible to obtain, direct observation of pain-related behaviors is highly recommended in this population.16,74 More than 24 behavioral tools have been developed for older adult patients with cognitive deficits.75 The Pain Assessment Checklist for Seniors with Limited Ability to Communicate (PACSLAC),76 Doloplus-2,77 and the Pain Assessment in Advanced Dementia (PAINAD)78 are promising tools that are recommended by experts.75,79

Delirium is a form of transient cognitive impairment that is highly prevalent among older adult patients in the critical care unit.80 A major challenge with delirium is that there is overlap between delirium behaviors and pain-related behaviors. It remains unclear whether pain behavioral tools may assist the nurse in the detection of pain in older adult patients during episodes of delirium. Because pain is a modifiable factor of delirium, it can be controlled with adequate pain management.81

Neonates and Infants

Two-way verbal communication is impossible with critically ill infants, and this remains an important barrier to pain assessment. The misconception that preterm neonates were incapable of pain sensation has persisted for a long time. Evidence supports that term and preterm neonates have the anatomic and functional capacity for pain sensation at birth.82 One critical review examined more than 35 instruments used to assess pain in neonates and infants.83 The Premature Infant Pain Profile (PIPP)84 is the most recommended valid tool for pain assessment of infants, and it has been implemented in many clinical settings. The PIPP includes behavioral and physiologic indicators. The emphasis in pain assessment should be on behavioral indicators. Physiologic indicators should be interpreted with caution because they are also affected by disease, medications, and physiologic status.16

Cultural Influences. 

Another barrier to accurate pain assessment is cultural influences on pain and pain reporting.85 Cultural influences are compounded when the patient speaks a language other than that of the health team members. To facilitate communication, the use of a pain intensity scale in the patient’s language is vital. The 0 to 10 numeric pain scales have been translated into many different languages.24

Although this chapter does not address specific cultural groups and their typical responses to pain, a few generalizations can be made. First, when assessing a patient from a cultural group different from your own, do not assume the patient will have a specific response to pain or exhibit a particular behavior because of his or her culture. Patients have individual responses to pain. The health care practitioner may wrongfully assign or expect behaviors that a patient will not exhibit. A second consideration that is commonly overlooked is the role of pain in the life of the patient. The nurse must communicate with the patient or the family to ascertain what that role is.

Some cultures believe that God’s test or punishment takes the form of pain. Persons with these cultural backgrounds do not necessarily believe that the pain should be relieved. Other cultures perceive pain as being associated with an imbalance in life. Persons from these cultures believe they need to manipulate the environment to restore balance to control pain.85

The complexities and intricacies of cultural beliefs require more extensive discussion than is possible here. It is important for the nurse to support, whenever possible, the special beliefs and needs of the patient and his family to provide the most therapeutic environment for healing to occur.

Lack of Knowledge

A relatively overlooked patient barrier to accurate pain assessment is the public knowledge deficit regarding pain and pain management. Many patients and their families are frightened by the risk of addiction to pain medication. They fear that addiction will occur if the patient is medicated frequently or with sufficient amounts of opioids necessary to relieve the pain. This concern is so powerful for some that they will deny or deliberately underreport the frequency or intensity of pain. Another misconception held by some patients is the expectation that unrelieved pain is simply part of a critical illness or procedure.86 Many patients have no memory of receiving an explanation of their pain-management plan.87 With that in mind, it is important that the critical care nurse teach the family and the patient about the importance of pain control and the use of opioids in treating pain in the critically ill.

Health Professional Barriers to Pain Assessment and Management

The health professional’s beliefs and attitudes about pain and pain management are frequently a barrier to accurate and adequate pain assessment. This can lead to poor management practices. Misconceptions or lack of knowledge regarding addiction, physiologic dependence, drug tolerance, and respiratory depression remain. Addiction rates for patients in acute pain who receive opioid analgesics are less than 1%. Some of the false beliefs that surround addiction result from a lack of knowledge about addiction and tolerance, and other concerns are related to the possible side effects of opioids.

Organizational Barriers to Pain Assessment and Management

The organizational system influences pain and pain-management practices as well as associated outcomes. Failure to make pain management a priority is the initial barrier. Failure to adopt standard pain assessment tools or to provide staff with sufficient time to assess and document pain, and a lack of accountability for pain-management practices are observed in some organizations. Evidence has demonstrated the lack of documentation of pain assessment and the undertreatment of pain in critical care settings.5,90, 91 The lack of collaboration between physicians and nurses is identified as a barrier to effective pain management.92

Because unrelieved pain is harmful to patients and increases the cost of care, it must be a priority for the health organization. Every organization must analyze their pain-management issues and practices and provide education about pain and pain management to staff. Now that pain is considered as the fifth vital sign, pain assessment must be included in documentation systems as a standard. Pain has to be assessed in all critically ill patients, regardless of their clinical condition or their level of consciousness. The implementation of pain assessment tools is essential so that the health care team can establish a common language of communication. This can facilitate interprofessional collaboration. There is an increased commitment to clinical practice guidelines and standards for pain assessment and management by organizations such as The Joint Commission (http://www.jointcommission.org), which have considerable influence in health care institutions. In addition, strategies to enhance collaboration among health professionals may include interdisciplinary care rounds or case reviews.92 Patients have the right to be consulted about their pain care plan and should be involved in making decisions. The organization must continually evaluate outcomes and work to improve the quality of pain management.

Pain Management

The management of pain in the critically ill patient is as multidimensional as the assessment. It is a multidisciplinary task. The control of pain can be pharmacologic, nonpharmacologic, or a combination of the two therapies. Pharmacologic pain management is predominantly used in critical care.

Pharmacologic Control of Pain

Pharmacologic management of pain has infinite variety in the critical care unit. Although this chapter is not an in-depth discussion of pharmacology, some commonly administered agents are discussed. Pain pharmacology is divided into three categories of action: opioid agonists, nonopioids, and adjuvants. Elements of the pain and analgesia clinical guidelines17 of the Society of Critical Care Medicine (SCCM) for the treatment of pain in the critically ill adult are presented in Box 9-2. A care bundle for pain assessment and management in the critical care unit was created to facilitate the translation of the SCCM practice guidelines to the bedside and is shown in Figure 9-6. How pain is approached and managed is a progression or combination of the available agents, the type of pain, and the patient response to the therapy. Figure 9-7 illustrates the analgesic action sites in relation to nociception.

Opioid Analgesics

The opioids most commonly used and recommended as first-line analgesics are the agonists. These opioids bind to mu (µ) receptors (transmission process; see Fig. 9-7), which appear to be responsible for pain relief. Additional pharmacologic information is presented in Table 9-3. In the SCCM guidelines, opioids should be used as first line therapy for treatment of non-neuropathic pain.17

TABLE 9-3

PHARMACOLOGIC MANAGEMENT
Pain

MEDICATION DOSAGE ONSET (min) DURATION (hr) AVAILABLE ROUTES PROPERTIES SIDE EFFECTS AND COMMENTS
Morphine 1-4 mg IV bolus 5-10 3-4 PO, SL, R, IV, IM, SC, EA, IA Analgesia, antianxiety Standard for comparison
  1-10 mg IV infusion         Side effects: sedation, respiratory depression, euphoria or dysphoria, hypotension, nausea, vomiting, pruritus, constipation, urinary retention
            M6G can accumulate in renal failure or hepatic dysfunction patients.
Fentanyl 25-100 mcg IV bolus 1-5 0.5-4 OTFC, IV, IM, TD, EA, IA Analgesia, antianxiety Same side effects as morphine
  25-200 mcg IV infusion         Rigidity with high doses
Hydromorphone (Dilaudid) 0.2-1 mg IV bolus
0.2-2 mg IV infusion
5 3-4 PO, R, IV, IM, SC, EA, IA Analgesia, antianxiety Same side effects as morphine
Codeine 15-30 mg IM, SC 10-20 3-4 PO, IM, SC Analgesia (mild to moderate pain) Lacks potency (unpredictable absorption; not all patients convert it to an active form to achieve analgesia)
            Most common side effects: light-headedness, dizziness, shortness of breath, sedation, nausea, and vomiting
Methadone (Dolophine) 5-10 mg IV 10 4-8 PO, SL, R, IV, SC, IM, EA, IA Analgesia Usually less sedating than morphine, but repeated doses can result in accumulation and can cause serious sedation (2-5 days).
Acetaminophen 650 mg maximum of 4 g/day 20-30 4-6 PO, R Analgesia, antipyretic Rare side effects
Hepatotoxicity
Ketorolac (Toradol) 15-30 mg IV <10 6-8 PO, IM, IV Analgesia, minimum antiinflammatory effect Short-term use (<5 days)
            Side effects: gastric ulceration, bleeding, exacerbation of renal insufficiency
            Use with care in older adult and renal failure patients.

image

EA, Epidural analgesia; IA, intrathecal analgesia; IM, intramuscular; IV, intravenous; M6G, morphine-6-glucuronide; OTFC, oral transmucosal fentanyl citrate; PO, oral; R, rectal; SC, subcutaneous; SL, sublingual; TD, transdermal.

Morphine. 

Morphine is the most commonly prescribed opioid in the critical care unit. Because of its water solubility, morphine has a slower onset of action and a longer duration compared with the lipid-soluble opioids (e.g., fentanyl). Morphine has two main metabolites: morphine-3-glucuronide (M3G, inactive) and morphine-6-glucuronide (M6G, active). M6G is responsible for the analgesic effect but may accumulate and cause excessive sedation in patients with renal failure or hepatic dysfunction.93 Morphine is available in a variety of delivery methods. It is the standard by which all other opioids are measured. It is also the agent that most closely mimics the endogenous opioids in the human pain modification system.

Morphine is indicated for severe pain. It has additional actions that are helpful for managing other symptoms. Morphine dilates peripheral veins and arteries, making it useful in reducing myocardial workload. Morphine is also viewed as an antianxiety agent because of the calming effect it produces.

Many side effects have been reported with the use of morphine (see Table 9-3). The hypotensive effect can be particularly problematic in the hypovolemic patient. The vasodilation effect is potentiated in the volume-depleted patient, and the hemodynamic status must be carefully monitored. Volume resuscitation restores blood pressure in the event of a prolonged hypotensive response.

A more serious side effect requiring diligent monitoring is the respiratory depressant effect. Opioids may cause this complication because they reduce the responsiveness of carbon dioxide chemoreceptors in the respiratory center located in the medulla.94 Although infrequent, this effect can have significant sequelae for the critically ill patient. Many risk factors for opioid-induced respiratory depression have been identified.24 From these, advanced age, obesity, sleep apnea, impaired renal/pulmonary/hepatic/cardiac functioning, patients in whom pain is controlled after a period of poor control, patients who are opiate naïve (i.e., receiving opiates for less than a week), concurrent use of central nervous system depressants, and postoperative day 1 were described.89 The critical care nurse must monitor the patient intensively to prevent this complication. Monitoring of patients receiving opioid analgesics is discussed in more detail later in this chapter. In addition to side effects common to all opioids, morphine may stimulate histamine release from mast cells, resulting in cardiac instability and allergic reactions.

Fentanyl. 

Fentanyl is a synthetic opioid preferred for critically ill patients with hemodynamic instability or morphine allergy. It is a lipid-soluble agent that has a more rapid onset than morphine and a shorter duration.95 The metabolites of fentanyl are largely inactive and nontoxic, which makes it an effective and safe opioid. Fentanyl or hydromorphone are preferred in hemodynamically unstable as well as in renal impaired patients.95 It is available in intravenous, intraspinal, and transdermal forms. The transdermal form is commonly referred to as the Duragesic patch or the 72-hour patch.

Because the side effects of fentanyl are similar to those of morphine, the nurse must monitor carefully the hemodynamic and respiratory response. When fentanyl is given by rapid administration and at higher doses, it has been associated with the additional hazard of bradycardia and rigidity in the chest wall muscles.93,96 The use of transdermal fentanyl is indicated rarely in the critically ill patient. The customary use of the “fentanyl patch” is for those experiencing chronic pain or cancer pain, and in critical care, it is used for the patient who requires extended pain control. Transdermal delivery requires 12 to 16 hours for onset of action, and it has a duration of 72 hours.24 If this delivery method is used, the patient will require other opioid management until the transdermal fentanyl takes effect.

Hydromorphone. 

Hydromorphone is a semisynthetic opioid that has an onset of action and a duration similar to those of morphine.96 It is an effective opioid with multiple routes of delivery. It is more potent than morphine. Hydromorphone produces an inactive metabolite (i.e., hydromorphone-3-glucuronide), making it the opioid of choice for use in patients with end-stage renal disease.99 Studies have shown that some side effects (e.g., pruritus, sedation, nausea, vomiting) may occur less with hydromorphone than morphine.97

Codeine. 

Codeine has limited use in the management of severe pain. It is rarely used in the critical care unit. It provides analgesia for mild to moderate pain. It is usually compounded with a nonopioid (e.g., acetaminophen). To be active, codeine must be metabolized in the liver to morphine.24 Codeine is available only through oral, intramuscular, and subcutaneous routes, and its absorption can be reduced in the critical care patient by altered gastrointestinal motility and decreased tissue perfusion.

More Potent Opioids: Remifentanil and Sufentanil. 

Remifentanil and sufentanil are agonist opioids. The use of these potent medications has been studied in critically ill patients.

Remifentanil is 250 times more potent than morphine, and it has a rapid onset and predictable offset of action. For this reason, it allows a rapid emergence from sedation, facilitating the evaluation of the neurologic state of the patient after stopping the infusion.101,102 As opposed to fentanyl, the use of remifentanil was associated with a lower incidence of postoperative delirium.103

Sufentanil is 7 to 13 times more potent than fentanyl and 500 to 1000 times more potent than morphine. It has more pronounced sedation properties than fentanyl and other opioids. Patients under sufentanil require minimal sedative agent doses to achieve an adequate sedation level. It has a rapid distribution and a high clearance rate, preventing accumulation when given for a long period.104 Sufentanil has a longer emergence from sedation compared with remifentanil, but it allows a longer analgesic effect after stopping its administration.102

Preventing and Treating Respiratory Depression

Respiratory depression is the most life-threatening opioid side effect. The risk of respiratory depression increases when other medications with CNS depressant effects (e.g., benzodiazepines, antiemetics, neuroleptics, antihistamines) are concomitantly administered to the patient. While no universal definition of respiratory depression exists, it is usually described in terms of decreased respiratory rate (fewer than 8 or 10 breaths/min), decreased Spo2 levels, or elevated ETCO2 levels.94 A change in the patient’s level of consciousness or an increase in sedation normally precedes respiratory depression.

Monitoring. 

Recent guidelines on monitoring for patients receiving opioid analgesia of ASPMN were established.94 In addition to assessing pain intensity as a targeted outcome of analgesia, regular sedation and respiratory assessments should be done. Valid and reliable sedation scales developed for use in critically ill patients should be used. Respirations should be evaluated over 1 minute and qualified according to rate, rhythm, and depth of chest excursion. The use of technology-supported monitoring (e.g., continuous pulse oximetry and capnography) can be useful in high-risk patients. More vigilant monitoring should be performed when patients may be at greater risk, such as during the first 24 hours after surgery, after an increase in the dose of an opioid, or a change in opioid agent or route of administration. For instance, Pasero et al have suggested monitoring these parameters at least every 2 hours for the first 24 hours and every 4 hours thereafter in stable patients.105

Snoring is a warning sign. It can be a sign of respiratory depression associated with airway obstruction by the tongue, leading to hypoxemia and possibly to cardiorespiratory arrest.24 A patient snoring after the administration of an opioid requires the critical care nurse to observe closely.

Opioid Reversal. 

Critical respiratory depression can be readily reversed with the administration of the opiate antagonist naloxone.24 The usual dose is 0.4 mg, which is mixed with 10 mL of normal saline (for a concentration of 0.04 mg/mL). Naloxone is normally given intravenously very slowly (0.5 mL over 2 minutes) while the patient is carefully monitored for reversal of the respiratory signs. Naloxone administration can be discontinued as soon as the patient is responsive to physical stimulation and able to take deep breaths. However, the medication should be kept nearby. Because the duration of naloxone is shorter than most opioids, another dose of naloxone may be needed as early as 30 minutes after the first dose. The nurse must monitor sedation and respiratory status and remind the patient to breathe deeply every 1 to 2 minutes until he or she becomes more alert. The benefits of reversing respiratory depression with naloxone must be carefully weighed against the risk of a sudden onset of pain and the difficulty achieving pain relief. To prevent this from occurring, it is important to provide a nonopioid medication for pain relief. Moreover, the use of naloxone is not recommended after prolonged analgesia, because it can induce withdrawal and may cause nausea and cardiovascular complications (e.g., dysrhythmias).

New Sedative with Analgesic Properties: Dexmedetomidine

Dexmedetomidine (Precedex) is a short-acting alpha 2 agonist that is indicated for the short-term sedation (<24 hours) of mechanically ventilated patients in the critical care unit.106 Its mechanism of action is unique and differs from those of other commonly used sedatives in critical care. Indeed, compared to midazolam (Versed) or lorazepam (Ativan)—whose hypnotic effects act mainly on the limbic system and/or the cortex—the effect of dexmedetomidine is located in the locus ceruleus section of the brainstem. As a result, patients receiving dexmedetomidine IV infusions are calm and sleepy, yet they remain easily arousable.107 For this reason, dexmedetomidine is ideal for mild to moderate sedation, often referred to as conscious sedation. Refer to the Sedation and Delirium Management chapter for details on dosage and administration.

Dexmedetomidine also possesses an analgesic property. The analgesic effects of dexmedetomidine are principally due to spinal antinociception via binding to non-noradrenergic receptors (heteroreceptors) located on the dorsal horn neurons of the spinal cord.105 Recently, dexmedetomidine was found to decrease postoperative opioid requirements in both adults and children.109,110 These results suggest that dexmedetomidine could be of interest with respect to improving postoperative pain in critical care.

While dexmedetomidine is increasing in popularity for short-term sedation in the critical care unit, it is not without adverse effect. Indeed, inhibition of noradrenergic receptors in the brainstem and the spinal cord often causes hypotension and bradycardia.107 Less common adverse effects include decreased salivation, decreased secretion, and decreased bowel motility in the gastrointestinal tract; contraction of vascular and other smooth muscle; inhibition of renin release, increased glomerular filtration, and increased secretion of sodium and water in the kidney; decreased intraocular pressure; and decreased insulin release from the pancreas.108

Nonopioid Analgesics

In the SCCM guidelines, the use of nonopioids in combination with an opioid is recommended to reduce opioid requirements and opioid related side effects.17 This strategy provides greater analgesic effect through action at the peripheral and central levels. Pharmacologic information is presented in Table 9-3.

Acetaminophen. 

Acetaminophen is an analgesic used to treat mild to moderate pain. It inhibits the synthesis of neurotransmitter prostaglandins in the CNS, and this is why it has no antiinflammatory properties.111 Acetaminophen is metabolized by two pathways: major (nontoxic metabolite) and minor (toxic metabolite that is rapidly converted into a nontoxic form by glutathione). In an acetaminophen overdose, a larger amount is processed by the minor pathway, and this results in a larger quantity of toxic metabolites and may cause damage to the liver. Side effects are rare at therapeutic doses (total daily dose should not exceed 4 g in 24 hours). Nonopioids are rarely used alone in critically ill patients. The nurse must consider the other products containing acetaminophen that the patient may receive when calculating the total daily dose of acetaminophen. Special care must be taken for patients with liver dysfunction, malnutrition, or a history of excess alcohol consumption, and their acetaminophen total dose should not exceed 2 g/day.17

Nonsteroidal Antiinflammatory Drugs. 

The use of NSAIDs in combination with opioids is indicated in the patient with acute musculoskeletal and soft tissue inflammation.24 The mechanism of action of NSAIDs is to block the action of cyclooxygenase (COX, which has two forms: COX-1 and COX-2), the enzyme that converts arachidonic acid to prostaglandins. This inhibits the production of prostaglandins (transduction process; see Fig. 9-7). This action occurs in the PNS and the CNS components of pain. NSAIDs can be grouped as first-generation (COX-1 and COX-2 inhibitors, such as aspirin, ibuprofen, naproxen, and ketorolac) or second-generation (COX-2 inhibitors, such as celecoxib) agents. The inhibition of COX-1 is thought to be responsible for many of the side effects, such as gastric ulceration, bleeding as a result of platelet inhibition, and acute renal failure. In contrast, the inhibition of COX-2 is responsible for the suppression of pain and inflammation.111 Second-generation NSAIDs are associated with minimal risks of serious adverse effects, but their role in critically ill patients remains unknown.17

Ketorolac is the most appropriate NSAID for use in the critical care setting. Research has shown that it is a safe and effective agent for postoperative pain.112 Not all critically ill patients are candidates for ketorolac therapy because of its side effects. Caution is advised for using ketorolac in older adults or patients with kidney dysfunction because of their slower clearance rates. Because ketorolac is an NSAID, monitoring for clumping of platelets is of primary importance. Laboratory data should be evaluated for an increase in bleeding time, and the patient should be assessed for any signs of abnormal bleeding. Moreover, prolonged use of ketorolac for more than 5 days was associated with an increase in kidney failure and bleeding.113,114 It is important to consider the concurrent use of opioids and NSAIDs to affect pain modification at both areas of transmission. This combination of agents often significantly reduces the amount of opioids required for effective pain management.

Other pharmacologic agents are used in the critical care unit. The most important factor to be considered in the management of pain with any pharmacologic agent is the careful assessment and reassessment of the patient’s pain status during the administration of the medication. The need to adjust the dosage, increase the frequency, or change the agent is based on assessment findings. The use of a pain flow sheet allows ongoing pain assessment and complete documentation of pain management in the critical care setting.

Adjuvants. 

Although not widely mentioned in the critical care literature, adjuvants can be helpful for pain relief in patients with complex pain syndromes such as neuropathic pain or for other specific purposes (e.g., procedural pain). Anticonvulsants (e.g., carbamazepine, phenytoin, gabapentin, pregabalin) are first-line analgesics for lancing neuropathic pain. The use of gabapentin or carbamazepine, in addition to intravenous opioids, is recommended for treatment of neuropathic pain in the SCCM guidelines.17 Even if the specific mechanism for pain relief is unknown, analgesia probably results from the suppression of sodium ion (Na+) discharges, reducing the neuronal hyperexcitability (action potential) in the transduction process24 (see Fig. 9-7). Antidepressants are also considered as analgesics in a variety of chronic pain syndromes, such as headache, fibromyalgia, low back pain, neuropathy, central pain, and cancer pain. The analgesic dose is often lower than that required to treat depression. Antidepressant adjuvant analgesics are usually divided into two main groups: tricyclic antidepressants (e.g., amitriptyline, imipramine, desipramine), and biogenic amine reuptake inhibitors (e.g., venlafaxine, paroxetine, sertraline). The mechanism of analgesia most widely accepted is the ability of antidepressants to block the reuptake of neurotransmitters serotonin and norepinephrine in the CNS.24 This increases the activity of the modulation process (see Fig. 9-7).

Ketamine. 

Anesthetics may be used to treat pain in the critical care setting. Ketamine is a dissociative anesthetic agent that has analgesic properties. It was traditionally used intravenously for procedural pain in burn patients. It is also available in enteral routes. Compared with opioids, ketamine has the benefit of sparing the respiratory drive, but it has many side effects related to the release of catecholamines and the emergence of delirium. For this reason, ketamine is not recommended for routine therapy in critically ill patients.96,112 Before administering ketamine, the dissociative state should be explained to the patient. Dissociative state refers to the feelings of separateness from the environment, loss of control, hallucinations, and vivid dreams. The use of benzodiazepines (e.g., midazolam) can reduce the incidence of this unpleasant effect.24

Delivery Methods

The most common route for medication administration is the intravenous route by means of continuous infusion, bolus administration, or patient-controlled analgesia (PCA). Traditionally, the choice has been intravenous bolus administration. The benefits of this method are the rapid onset of action and the ease of titration. The major disadvantage is the rise and fall of the serum level of the opioid, leading to periods of pain control with periods of breakthrough pain.111

Continuous infusion of opioids with an infusion pump provides constant blood levels of the ordered opioid. This promotes a consistent level of comfort. It is a particularly helpful method of administration during sleep because the patient awakens with an adequate level of pain relief. It is important that the patient be given the loading dose that relieves the pain and raises the circulating dose of the medication. After the basal rate is established, the patient maintains a steady state of pain control unless there is additional pain from a procedure, an activity, or a change in the patient’s condition. In this situation, physician orders to administer additional boluses of opioid need to be available.

Patient-Controlled Analgesia

PCA is a method of medication delivery that uses the intravenous route and an infusion pump. It allows the patient to self-administer small doses of analgesics. Different opioids can be used, but the most extensively used is morphine. This method of medication delivery allows the patient to control the level of pain and sedation and to avoid the peaks and valleys of intermittent dosing by the health care professional. The patient can self-administer a bolus of medication the moment the pain begins, acting preemptively. Nursing management for the patient receiving analgesia medication via a PCA pump is described in the Nursing Interventions Classification (NIC) feature in Box 9-3.

image Box 9-3

NIC

Patient-Controlled Analgesia (PCA) Assistance

Activities

Collaborate with physicians, patient, and family members in selecting the type of narcotic to be used

Recommend administration of aspirin and nonsteroidal antiinflammatory drugs in conjunction with narcotics, as appropriate

Recommend discontinuation of opioid administration by other routes

Avoid use of meperidine hydrochloride (Demerol)

Ensure that patient is not allergic to analgesic to be administered

Instruct patient and family to monitor pain intensity, quality, and duration

Instruct patient and family to monitor respiratory rate and blood pressure

Establish nasogastric, venous, subcutaneous, or spinal access, as appropriate

Validate that the patient can use a PCA device (is able to communicate, comprehend explanations, and follow directions)

Collaborate with patient and family to select appropriate type of patient-controlled infusion device

Instruct patient and family members how to use the PCA device

Assist patient and family to calculate appropriate concentration of drug to fluid, considering the amount of fluid delivered per hour via the PCA device

Assist patient or family member to administer an appropriate bolus loading dose of analgesic

Instruct the patient and family to set an appropriate basal infusion rate on the PCA device

Assist the patient and family to set the appropriate lockout interval on the PCA device

Assist the patient and family in setting appropriate demand doses on the PCA device

Consult with patient, family members, and physician to adjust lockout interval, basal rate, and demand dosage, according to patient responsiveness

Instruct patient how to titrate doses up or down, depending on respiratory rate, pain intensity, and pain quality

Instruct the patient and family members the action and side effects of pain-relieving agents

Recommend a bowel regimen to avoid constipation

Consult with clinical pain experts for a patient who is having difficulty achieving pain control

From Bulechek GM, et al. Nursing interventions classification (NIC). 6th ed. St. Louis: Mosby; 2013.

Certain patients are not candidates for PCA. Alterations in the level of consciousness or mentation preclude the patient understanding the use of the equipment. Very elderly patients or patients with kidney failure or liver dysfunction may require careful screening for PCA.

Allowing the patient to self-administer opioid doses does not diminish the role of the critical care nurse in pain management. The nurse advises about necessary changes to the prescription and continues to monitor the effects of the medication and doses. The patient is closely monitored during the first 2 hours of therapy and after every change in the prescription. If the patient’s pain does not respond within the first 2 hours of therapy, a total reassessment of the pain state is essential. The nurse monitors the number of boluses the patient delivers. If the patient is pressing the button to bolus medication more often than the prescription, the dose may be insufficient to maintain pain control. Naloxone must be readily available to reverse adverse opiate respiratory effects. Ideally, the patient undergoing an elective procedure requiring opioid analgesia postoperatively is instructed in the use of PCA during preoperative teaching. This allows the patient to become comfortable with the concept of self-medication before use.

Intraspinal Pain Control

Intraspinal anesthesia uses the concept that the spinal cord is the primary link in nociceptive transmission. The goal is to mimic the body’s endogenous opioid pain modification system by interfering with the transmission of pain and providing an opiate receptor binding agent directly into the spinal cord. The hemodynamic status of the patient changes very little.

Intraspinal anesthesia is particularly appropriate for pain in the thorax, upper abdomen, and lower extremities. The two intraspinal routes are intrathecal and epidural (Fig. 9-8). Regardless of the route, the effects of the opioid agonist used is the same, and assessment parameters are the same as those used for other routes. Nursing management of the patient receiving intraspinal analgesia is described in the Nursing Interventions Classification (NIC) feature in Box 9-4.

image Box 9-4

NIC

Analgesic Administration: Intraspinal

Activities

Check patency and function of the catheter, port, and/or pump

Ensure that intravenous access is in place at all times during therapy

Label the catheter, and secure it appropriately

Ensure that the proper formulation of the drug is used (e.g., high concentrating and preservation free)

Ensure narcotic antagonist availability for emergency administration and administer per physician order, as necessary

Start continuous infusion of analgesic agent after correct catheter placement has been verified, and monitor rate to ensure delivery of prescribed dosage of medication

Monitor temperature, blood pressure, respirations, pulse, and level of consciousness at appropriate intervals, and record on flow sheet

Monitor level of sensory blockade at appropriate intervals, and record on flow sheet

Monitor catheter site and dressings to check for a loose catheter or wet dressing, and notify appropriate personnel per agency protocol

Administer catheter site care according to agency protocol

Secure needle in place with tape and apply appropriate dressing according to agency protocol

Monitor for adverse reactions, including respiratory depression, urinary retention, undue somnolence, itching, seizures, nausea, and vomiting

Monitor orthostatic blood pressure and pulse before the first attempt at ambulation

Instruct patient to report side effects, alterations in pain relief, numbness of extremities, and need for assistance with ambulation if weak

Follow institutional policies for injection of intermittent analgesic agents into the injection port

Provide adjunct medications as appropriate (e.g., antidepressants, anticonvulsants, nonsteroidal antiinflammatory agents)

Increase the intraspinal dose based on a pain intensity score

Instruct and guide patient through nonpharmacologic measures (e.g., relaxation therapy, guided imagery, and biofeedback) to enhance pharmacologic effectiveness

Instruct patient about proper home care for external or implanted delivery systems, as appropriate

Remove or assist with removal of catheter according to agency protocol

From Bulechek GM, et al. Nursing interventions classification (NIC). 6th ed. St. Louis: Mosby; 2013.

Epidural Analgesia

Epidural analgesia is commonly used in the critical care unit after major abdominal surgery, nephrectomy, thoracotomy, and major orthopedic procedures. Per the SCCM guidelines, its use should be considered in postoperative abdominal aortic aneurysm patients, and for those with traumatic rib fractures.17 Certain conditions preclude the use of this pain control method: systemic infection, anticoagulation, and increased intracranial pressure. Epidural delivery of opiates provides longer-lasting pain relief with less dosing of opiates. When delivered into the epidural space, 5 mg of morphine may be effective for 6 to 24 hours, compared with 3 to 4 hours when delivered intravenously. Opioids infused in the epidural space are more unpredictable than those administered intrathecally. The epidural space is filled with fatty tissue and is external to the dura mater. The fatty tissue interferes with uptake, and the dura acts as a barrier to diffusion, making diffusion rate difficult to predict.

The type of medication used determines the rapidity of medication diffusion. Hydrophilic medications (e.g., morphine) are water soluble and penetrate the dura slowly, giving them a longer onset and duration of action. Lipophilic medications (e.g., fentanyl) are lipid soluble; they penetrate the dura rapidly and therefore have a rapid onset of action and a shorter duration of action.

The dura acts as a physical barrier and causes delay in diffusion of the medication. Compared with the intrathecal route, it allows more medication to be absorbed in the systemic circulation, requiring greater doses for pain relief. Medications delivered epidurally may be administered by bolus or continuous infusion. Epidural analgesia is being used more often in the critical care environment, and it requires careful monitoring.

The nurse must assess the patient for respiratory depression. This phenomenon may occur early in the therapy or as late as 24 hours after initiation. The epidural catheter also puts the patient at risk for infection. The efficiency of this pain control method and the increased mobility of the patient do not diminish the nurse’s responsibility to monitor and evaluate the outcomes of the pain-management protocol in use.

Equianalgesia

When a modification of opioid is considered, the nurse must be aware of equianalgesic dosages. In doing any conversion, the goal is to provide equal analgesic effects with the new agents. This concept is referred to as equianalgesia. Morphine is the standard for the conversion of opioids. Prescribed dosages must take into account the patient’s age and health status.24 The critical care nurse must have access to a chart for easy referral on the unit to administer the correct dosages of opioids to critically ill patients. Because of the variety of agents and routes, the professional pain organizations have developed equianalgesia charts for use by the health care professional. All critical care units need to have an equianalgesic chart posted for easy reference. Box 9-5 presents a guide to using these charts. Table 9-4 provides the equianalgesic dose for different medications used in clinical practice. Table 9-5 presents an equianalgesic chart with PO nonopioid and opioid doses for mild to moderate pain.

TABLE 9-4

EQUIANALGESIC CHART
Approximate Equivalent Doses of Opioids for Moderate-to-Severe Pain

ANALGESIC PARENTERAL (IM, SC, IV) ROUTE1,2 (mg) PO ROUTE1 (mg) COMMENTS
Mu Opioid Agonists      
Morphine 10 30 Standard for comparison; multiple routes of administration; available in immediate-release and controlled-release formulations; active metabolite M6G can accumulate with repeated dosing in renal failure
Codeine 130 200 NR IM has unpredictable absorption and high side-effect profile; used PO for mild-to-moderate pain; usually compounded with nonopioid (e.g., Tylenol No. 3)
Fentanyl 100 mcg/hr parenterally and transdermally ≅ 4 mg/hr morphine parenterally; 1 mcg/hr transdermally ≅ 2 mg/24 hr morphine PO Short half-life, but at steady state, slow elimination from tissues can lead to a prolonged half-life (up to 12 hr); start opioid-naïve patients on no more than 25 mcg/hr transdermally; transdermal fentanyl NR for acute pain management; available by oral transmucosal route
Hydromorphone (Dilaudid) 1.5 7.5 Useful alternative to morphine; no evidence that metabolites are clinically relevant; shorter duration than morphine; available in high-potency parenteral formulation (10 mg/mL) useful for SC infusion; 3 mg rectal ≅ 650 mg aspirin PO; with repeated dosing (e.g., PCA), it is more likely than 2-3 mg parenteral hydromorphone =10 mg parenteral morphine
Levorphanol (Levo-Dromoran) 2 4 Longer-acting than morphine when given repeatedly; long half-life can lead to accumulation within 2-3 days of repeated dosing
Meperidine 75 300 NR No longer preferred as a first-line opioid for the management of acute or chronic pain due to potential toxicity from accumulation of metabolite, normeperidine; normeperidine has 15-20 hr half-life and is not reversed by naloxone; NR in elderly or patients with impaired renal functions; NR by continuous IV infusion
Methadone (Dolophine) 10 20 Longer-acting than morphine when given repeatedly; long half-life can lead to delayed toxicity from accumulation within 3-5 days; start PO dosing on PRN schedule; in opioid-tolerant patients converted to methadone, start with 10%-25% of equianalgesic dose
Oxycodone 20 Used for moderate pain when combined with a nonopioid (e.g., Percocet, Tylox); available as single entity in immediate-release and controlled-release formulations (e.g., OxyContin); can be used like PO morphine for severe pain
Oxymorphone (Numorphan) 1 10 rectal Used for moderate to severe pain; no PO formulation
Agonist-Antagonist Opioids: Not recommended for severe, escalating pain. If used in combination with mu agonists, may reverse analgesia and precipitate withdrawal in opioid-dependent patients.
Buprenorphine (Buprenex) 0.4 Not readily reversed by naloxone; NR for laboring patients
Butorphanol (Stadol) 2 Available in nasal spray
Dezocine (Dalgan) 10  
Nalbuphine (Nubain) 10  
Pentazocine (Talwin) 60 180  

image

Duration of analgesia is dose dependent; the higher the dose, usually the longer the duration.

IV boluses may be used to produce analgesia that lasts approximately as long as IM or SC doses. However, of all routes of administration, IV produces the highest peak concentration of the medication, and the peak concentration is associated with the highest level of toxicity, e.g., sedation. To decrease the peak effect and lower the level of toxicity, IV boluses may be administered more slowly, e.g., 10 mg of morphine over a 15-minute period, or smaller doses may be administered more often, e.g., 5 mg of morphine every 1-1.5 hours.

FDA, U.S. Food and Drug Administration; IM, intramuscular; IV, intravenous; M6G, morphine-6-glucuronide; MCG, micrograms; MG, milligrams; NR, not recommended; PCA, patient-controlled analgesia; PO, by mouth; PRN, pro re nata (as needed); SC, subcutaneous.

Reference: Pasero C, McCaffrey M. Pain Assessment and Pharmacologic Management, St. Louis: Elsevier; 2011. Table 16-1, p. 444-445.

Nonpharmacologic Methods of Pain Management

Although numerous methods of pain management other than medications appear in the critical care literature,115 very few studies have been done to provide evidence of their effectiveness in the critical care settings. Nonpharmacologic methods can be used to supplement analgesic treatment, but they are not intended to replace analgesics. In most instances, these therapies may enhance the pharmacologic management of the patient’s pain. Per the SCCM guidelines, administration of preemptive analgesic therapy and/or non-pharmacological interventions, it is suggested to alleviate pain during invasive or potentially painful procedures in critically ill adults.17

Critical care nurses identify many barriers to the use of non-pharmacologic methods for pain management, including a lack of knowledge, training, and time.116 Despite these problems, more than 60% of them are willing to use the methods to relieve their patients’ pain. It is crucial that critical care nurses be provided with the appropriate training and equipment required to apply nonpharmacologic methods for pain management in the critically ill.

Physical Techniques

Stimulating other non–pain sensory fibers (Aβ) in the periphery modifies pain transmission. These fibers are stimulated by thermal changes as in the application of heat or cold, and simple massage.

Cold Application

Ice therapy was found to be helpful to reduce procedural pain in critically ill patients. In a study with 50 cardiac surgery patients in a critical care unit, a significant decrease in pain intensity was obtained after chest tube removal when ice packets were placed around the site for 10 minutes prior to removal.117 The analgesic property of ice therapy was also studied by Demir and Khorshid118 using a 20-minute application of cold packs before chest tube removal in the critical care unit. Pain intensity was significantly lower after chest tube removal in patients who received the cold packs and a dose of analgesic compared with a placebo and a control group.

Massage

The effect of massage on pain relief was explored in two studies with postoperative cardiac surgery patients after they have been transferred from the critical care unit.119,120 In these two studies with a total of 171 patients, a significant decrease in pain intensity scores was obtained in patients who received a 20-minute massage intervention between postoperative day 2 and day 5 compared to a control group who received standard care and a 20-minute quiet time during the same period. Similar findings were found in the critical care unit. Indeed, in a recent pilot study121 with 40 postoperative cardiac surgery patients, a decrease in pain intensity scores was observed in patients who were administered two to three 15-minute hand massage sessions during the first 24 hours after surgery compared to a control group who did not receive hand massage but had the nurse holding their hands and reported no change in pain intensity.

Cognitive-Behavioral Techniques

Using the cortical interpretation of pain as the foundation, several interventions can reduce the patient’s pain report. These modalities include cognitive techniques such as relaxation, distraction, guided imagery, and music therapy.

Relaxation

Relaxation is a well-documented method for reducing the distress associated with pain. Although not a substitute for pharmacology, relaxation is an excellent adjunct for controlling pain. Relaxation decreases oxygen consumption and muscle tone, and it can decrease heart rate and blood pressure. Relaxation gives the patient a sense of control over the pain and reduces muscle tension and anxiety. Not all patients are interested in relaxation therapy. For those patients, deep-breathing exercises may be helpful. Indeed, in a recent study,3 lower pain scores were found both after chest tube removal in 40 critically ill patients executing deep breathing and receiving an analgesic compared to those who solely received an analgesic. Excellent references for thorough techniques in relaxation therapy are available.24

Music Therapy

Music therapy is a commonly used intervention for relaxation. Music that is pleasing to the patient may have soothing effects, but its effects on reducing pain are controversial.123 Ideally, the music should be supplied by a small set of headphones. It is important to educate the patient and family regarding the role of music in relaxation and pain control and to provide music of the patient’s choice.

The patient and family may provide information about other sources of distraction for the patient. Determining what distraction therapies the patient normally uses may provide a clue to which one may work during the illness. Some persons are distracted by television; for others, television is a source of increased anxiety. Do not assume that the patient does or does not want to watch television until you determine whether it will be beneficial or harmful to the patient.

Box 9-6   Case Study

Patient with Pain

Summary

• Pain in the critically ill patient is difficult to assess and manage. There are many sources of pain in the critical care setting, and the effects of unrelieved acute pain can have a significant impact on the patient’s recovery.

• When possible, the patient’s self-report of pain must be obtained. A simple yes or no communicated by head nodding from a mechanically ventilated patient is considered a valid self-report of pain.

• When the patient’s self-report is not available, behavioral indicators represent alternative measures of pain assessment, and assessment tools (e.g., BPS, CPOT) have been developed for assessment of pain in nonverbal critically ill patients.

• In some situations, behavioral indicators may be impossible to assess accurately. The use of physiologic indicators is then crucial. However, vital signs do not represent valid information for pain assessment. Innovative physiologic measures (e.g., BIS, EEG) are being explored and may support the nurses in the pain assessment process.

• The critical care nurse must collaborate with the multidisciplinary team to ensure a plan of care for management of the patient’s pain is developed. To fully participate, the nurse must have extensive knowledge of nonpharmacologic and pharmacologic therapies designed to achieve effective pain relief.